Could a simple shot replace IV drips for some cancer patients?
NCT ID NCT07161414
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 25 times
Summary
This early-stage study tests a new injection form of the cancer drug rilvegostomig in about 40 adults with advanced solid tumors that have already been treated. The goal is to find a dose that works as well as the current IV version and to check for side effects. Participants must have a life expectancy of at least 12 weeks and adequate organ function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGHuntersville, North Carolina, 28078, United States
-
Research Site
RECRUITINGSan Antonio, Texas, 78229, United States
-
Research Site
RECRUITINGFairfax, Virginia, 22031, United States
-
Research Site
NOT_YET_RECRUITINGSeoul, 03080, South Korea
-
Research Site
NOT_YET_RECRUITINGSeoul, 03722, South Korea
-
Research Site
NOT_YET_RECRUITINGBarcelona, 08035, Spain
-
Research Site
RECRUITINGBarcelona, 08036, Spain
-
Research Site
RECRUITINGMadrid, 28027, Spain
-
Research Site
RECRUITINGMadrid, 28040, Spain
-
Research Site
SUSPENDEDNewcastle upon Tyne, NE7 7DN, United Kingdom
-
Research Site
SUSPENDEDSutton, SM2 5PT, United Kingdom
Conditions
Explore the condition pages connected to this study.